Advertisement
Research Article

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials

  • Anke Schultz equal contributor,

    equal contributor Contributed equally to this work with: Anke Schultz, Stefanie Koch

    Affiliation: Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany

    X
  • Stefanie Koch equal contributor,

    equal contributor Contributed equally to this work with: Anke Schultz, Stefanie Koch

    Affiliation: Department of Virology, Saarland University, Homburg, Germany

    X
  • Martina Fuss,

    Affiliation: Department of Virology, Saarland University, Homburg, Germany

    X
  • Angela S. Mazzotta,

    Affiliation: Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany

    X
  • Marcella Sarzotti-Kelsoe,

    Affiliation: Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Daniel A. Ozaki,

    Affiliation: Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • David C. Montefiori,

    Affiliation: Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Hagen von Briesen,

    Affiliation: Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany

    X
  • Heiko Zimmermann,

    Affiliation: Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany

    X
  • Andreas Meyerhans mail

    andreas.meyerhans@upf.edu

    Affiliations: Department of Virology, Saarland University, Homburg, Germany, ICREA Infection Biology Laboratory, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain

    X
  • Published: December 27, 2012
  • DOI: 10.1371/journal.pone.0051715

Reader Comments (0)

Post a new comment on this article